California Pharmaceuticals LLC   Report issue

For profit Phase 3
Founded: Camarillo California United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2019
NCT04182880
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Cali Pharmaceuticals LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

ropivacaine (naropin) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1